Ibudilast is under clinical development by MediciNova and currently in Phase II for Chemotherapy Induced Peripheral Neuropathy.

Capsaicin is under clinical development by Grunenthal and currently in Phase III for Chemotherapy Induced Peripheral Neuropathy.

OUR resident specialist and NHS GP, Dr Zoe Williams, shares her expert advice. Today, Dr Zoe helps a reader who has painful ...

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) ...

blocker approved for the treatment of chronic inflammatory demyelinating polyneuropathy or CIDP. CIDP is a progressive, immune-mediated rare and debilitating neuromuscular disorder of the peripheral ...

According to the results of a new study, “cannabis-based medicines may be effective in treating the pain and symptoms of ...

Medically reviewed by Sarah Richards, DPM A burning sensation in your feet can happen for several reasons. Knowing the exact ...

Exercise interventions may help manage chemotherapy-induced peripheral neuropathy (CIPN) in patients with ovarian cancer ...

Diabetic peripheral neuropathy (DPN) is length-dependent ... including metabolic factors beyond hyperglycaemia, that could guide treatment and prevention strategies.

peripheral neuropathy happens a lot to people with chronic kidney disease (CKD). In CKD, the kidneys aren't able to clear toxins out of the blood as well as they should. This causes waste to build up, ...

Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.

Vertex announces data from a phase II study evaluating its NaV1.8 pain signal inhibitor, suzetrigine, for treating painful lumbosacral radiculopathy. Shares down.